Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.
Idro R, Nkosi-Gondwe T, Opoka R, Ssenkusu JM, Dennis K, Tsirizani L, Akun P, Rujumba J, Nambatya W, Kamya C, Phiri N, Joanita K, Komata R, Innussa M, Tenywa E, John CC, Tarning J, Denti P, Wasmann RE, Ter Kuile FO, Robberstad B, Phiri KS.
Idro R, et al. Among authors: john cc.
Lancet Infect Dis. 2024 Dec 20:S1473-3099(24)00737-0. doi: 10.1016/S1473-3099(24)00737-0. Online ahead of print.
Lancet Infect Dis. 2024.
PMID: 39718172